Please ensure Javascript is enabled for purposes of website accessibility

BD Innovation Center opens at UM BioPark

Becton, Dickinson and Company (BD), a global medical technology company, Wednesday officially opened the BD Innovation Center in collaboration with the University of Maryland BioPark, offering University of Maryland, Baltimore (UMB) students and researchers access to state-of-the-art equipment to support and accelerate innovation in medical diagnostic technology.

Located in West Baltimore at the UM BioPark, the BD Innovation Center is expected to help streamline clinical laboratory workflows and improve patient care by expanding basic diagnostic knowledge, developing new diagnostic capabilities and shaping the future of diagnostics by allowing students and researchers to provide real-world feedback on early diagnostic concepts.

Maryland Commerce Secretary Mike Gill presented Brooke Story, president of Integrated Diagnostic Solutions for BD, with a citation from Gov. Larry Hogan recognizing the history of BD in Maryland in honor of the company’s 125th anniversary.

The BD Innovation Center currently houses:

  • The BD COR PX/GX fully automated high-throughput diagnostic system, which uses robotics and sample management software algorithms for infectious disease molecular testing;
  • The BD MAX System for mid-throughput molecular applications, which includes a variety of clinically validated assays and an open system for sample-to-answer assay development;
  • The BD BACTEC™ FX for state-of-the-art blood culture detection of organisms; and
  • The BD Phoenix M50 for ID/AST providing sample-to-answer identification and antimicrobial susceptibility determinations.

The BD Integrated Diagnostic Solutions (IDS) business unit has its global headquarters in Sparks, with more than 2,200 associates responsible for developing and manufacturing the latest diagnostic technology solutions critical to identifying known and new pathogens. The site is integral to the company’s testing innovations around cervical cancer, respiratory infections, SARS-CoV-2 (COVID-19) as well as the ongoing fight against antimicrobial resistance.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.

By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.